Government response to the review into commercial clinical trials – The full government response to the Lord O’Shaughnessy independent review of UK commercial clinical trials.
Date: 23 November 2023
The government published its initial response to the Lord O’Shaughnessy review into UK commercial clinical trials in May 2023. The initial response welcomed all recommendations from the review in principle and made 5 headline commitments backed by up to £121 million funding.
This report published on November 22nd 2023 sets out the government’s response in full and integrates Lord O’Shaughnessy’s recommendations into the government’s programme of work to implement their bold and ambitious 10-year vision, Saving and Improving Lives: The Future of UK Clinical Research Delivery. The report provides:
- an update on progress made against the 5 headline commitments
- new national performance indicators which will drive progress in the delivery of clinical research across the UK
- a prioritised response on the remaining recommendations and the existing programme of work announced in the previous implementation plans, which this supersedes